High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection

Peer Review reports

Original Submission
15 Jan 2020	Submitted	Original manuscript
1 Feb 2020	Reviewed	Reviewer Report - Ulrich Friedrich Wellner
3 Feb 2020	Reviewed	Reviewer Report - Mariko Tanaka
18 Feb 2020	Author responded	Author comments - Takahiro Ito
Resubmission - Version 2
18 Feb 2020	Submitted	Manuscript version 2
Publishing
28 Feb 2020	Editorially accepted
12 Mar 2020	Article published	10.1186/s12885-020-6695-9

Back to article page